Jarrett Jennifer 4
4 · Sagimet Biosciences Inc. · Filed Jun 15, 2026
Insider Transaction Report
Form 4
Jarrett Jennifer
Director
Transactions
- Award
Stock Option (Right to Buy)
[F1]2026-06-12+39,567→ 39,567 totalExercise: $6.48Exp: 2036-06-11→ Series A Common Stock (39,567 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest and become exercisable over twelve (12) equal monthly installments following June 12, 2026, subject to the Reporting Person's continued service on each such vesting date.
Signature
/s/ Elizabeth Rozek, Attorney-in-Fact|2026-06-15